Alivus Life Sciences Incorporates Wholly Owned Pharmaceutical Subsidiary in Brazil
Alivus Life Sciences Ltd 路 Others (Uncategorized) 路 16 Sept 2026, 6:47 pm
Alivus Life Sciences Incorporates Wholly Owned Pharmaceutical Subsidiary in Brazil Alivus Life Sciences Limited incorporated a wholly owned subsidiary, Alivus Life Sciences Do Brasil Ltda., in Sao Paulo, Brazil, on 15th Sep'26. The new entity operates within the pharmaceutical industry. Alivus will hold 100% of the paid-up share capital via cash consideration, subscribing to an amount not exceeding R$ 500,000 across 500,000 shares. The incorporation has been approved by the Federative Republic of Brazil National Registrar of Legal Entities and does not fall under related-party transaction purview.
Original exchange filing (PDF)
More announcements from Alivus Life Sciences Ltd
- Enclosed please find herewith update on acquisition. 路 11 Nov 2026
- Please find enclosed herewith disclosure under Regulation 30 of SEBI(LODR), 2015. 路 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nirma Ltd 路 07 Nov 2026
- Please find attached herewith submission with respect to transcript of the earning call. 路 06 Nov 2026
- Please find enclosed herewith intimation for Analyst/Investor meeting. 路 04 Nov 2026
- Please find enclosed herewith intimation for Analyst/Investor Meet. 路 30 Oct 2026
- We hereby confirm that we have uploaded audio recording of the Q2 FY2027 Earnings Call held on October 30, 2026 on the website of the Company. 路 30 Oct 2026
- Please find enclosed herewith intimation with respect to allotment of equity shares under "Employee Stock Option Scheme, 2021" 路 30 Oct 2026
